Evidence Synthesis
INDOKEM Sees Accelerating Growth with Improved Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Revenue Growth.
Evidence Synthesis
Last synthesized: 5 Sept 2026, 04:09
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
INDOKEM Sees Accelerating Growth with Improved Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Revenue Growth.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 33.49 % | 3.45 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 3.45 % | 1.28 | ▲ |
| REVENUE_GROWTH_YOY | 12.2 % | 52 | ▼ |
| PRICE_CHANGE_PERCENT | 0.541 % | — | - |
| DAILY_VOLUME | 3,842 shares | 5,954 | ▼ |
| CLOSE_PRICE | 632.4 INR | 629 | ▲ |